146 related articles for article (PubMed ID: 9166984)
21. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
22. [Effect of perindopril on left ventricular structural and functional parameters in patients with preserved systolic function after myocardial infarction. Relation to polymorphism of angiotensin converting enzyme gene].
Tereshchenko SN; Dzhaiani NA; Moiseev VS; Nosikov VV
Kardiologiia; 2002; 42(5):38-41. PubMed ID: 12494147
[No Abstract] [Full Text] [Related]
23. Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme.
Dorer FE; Kahn JR; Lentz KE; Levine M; Skeggs LT
Biochem Pharmacol; 1975 May; 24(10):1137-9. PubMed ID: 168899
[No Abstract] [Full Text] [Related]
24. Conversion of angiotensin I to angiotensin II.
Erdös EG
Am J Med; 1976 May; 60(6):749-59. PubMed ID: 190881
[TBL] [Abstract][Full Text] [Related]
25. Enhanced expression of angiotensin II receptor subtypes and angiotensin converting enzyme in medroxyprogesterone-induced mouse mammary adenocarcinomas.
Guerra FK; Ciuffo GM; Elizalde PV; Charreau EH; Saavedra JM
Biochem Biophys Res Commun; 1993 May; 193(1):93-9. PubMed ID: 8389152
[TBL] [Abstract][Full Text] [Related]
26. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.
Fukuda N; Satoh C; Hu WY; Soma M; Kubo A; Kishioka H; Watanabe Y; Izumi Y; Kanmatsuse K
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1210-7. PubMed ID: 10323771
[TBL] [Abstract][Full Text] [Related]
27. Formation of angiotensin III by angiotensin-converting enzyme.
Chiu AT; Ryan JW; Stewart JM; Dorer FE
Biochem J; 1976 Apr; 155(1):189-92. PubMed ID: 180981
[TBL] [Abstract][Full Text] [Related]
28. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
Zhuo JL; Mendelsohn FA; Ohishi M
Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II.
van Kats JP; Duncker DJ; Haitsma DB; Schuijt MP; Niebuur R; Stubenitsky R; Boomsma F; Schalekamp MA; Verdouw PD; Danser AH
Circulation; 2000 Sep; 102(13):1556-63. PubMed ID: 11004147
[TBL] [Abstract][Full Text] [Related]
30. ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure.
Gold JA; Rahko PS
WMJ; 2004; 103(1):71-2. PubMed ID: 15101473
[No Abstract] [Full Text] [Related]
31. Interactions among ACE, kinins and NO.
Linz W; Wohlfart P; Schölkens BA; Malinski T; Wiemer G
Cardiovasc Res; 1999 Aug; 43(3):549-61. PubMed ID: 10690327
[No Abstract] [Full Text] [Related]
32. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
[TBL] [Abstract][Full Text] [Related]
33. Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction.
Ray SG; McAlpine HM; Morton JJ; Leckie B; Dargie HJ
Angiology; 1991 Apr; 42(4):268-72. PubMed ID: 2014917
[TBL] [Abstract][Full Text] [Related]
34. Renin-angiotensin system in human failing hearts: message from nonmyocyte cells to myocytes.
Matsubara H
Circ Res; 2001 May; 88(9):861-3. PubMed ID: 11348994
[No Abstract] [Full Text] [Related]
35. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
36. Cultured myofibroblasts generate angiotensin peptides de novo.
Katwa LC; Campbell SE; Tyagi SC; Lee SJ; Cicila GT; Weber KT
J Mol Cell Cardiol; 1997 May; 29(5):1375-86. PubMed ID: 9201623
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction.
McMurray JJ
Heart; 2001 Jul; 86(1):97-103. PubMed ID: 11410575
[No Abstract] [Full Text] [Related]
38. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
39. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Husain A; Li M; Graham RM
Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
[No Abstract] [Full Text] [Related]
40. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
